We present our experience of insulin replacement therapy (IRT) by co-transplantation of insulin-secreting adipose tissue derived mesenchymal stem cells (IS-AD-MSC) and cultured-bone-marrow- (CBM-) derived HSCT in 11 IDDM patients. The gene discussed is INS; the disease is type 1 diabetes mellitus.